Positrigo Secures $8.5M to Democratize Brain Imaging: A Game-Changer for Dementia Diagnosis

Positrigo is thrilled to announce our latest funding milestone of $8.5 million in a recent successful funding round, marking an exciting chapter in our mission to revolutionize brain health diagnostics. Dementia is a major challenge facing aging societies across the globe, incurring nearly a trillion dollars in costs annually, and current diagnostic techniques remain either too expensive or not widely accessible. At Positrigo, we are committed to changing that landscape by developing our innovative brain positron emission tomography (PET) system—a groundbreaking solution that provides functional brain imaging at a fraction of the cost of traditional methods. With this new capital injection, our team of dedicated scientists, engineers, and healthcare experts will accelerate development, enhance system capabilities, and expand our clinical trials to further validate the efficacy of our diagnostic tool. The funding will also support strategic partnerships with research institutions and healthcare providers, ensuring that our technology can reach the markets as swiftly and safely as possible. By making advanced brain imaging more affordable, we aim to empower earlier detection and intervention in neurodegenerative disorders such as dementia, ultimately improving outcomes and quality of life for millions. This investment represents not just a financial boost, but also a strong vote of confidence in our vision to democratize high-quality dementia diagnostics. At Positrigo, we believe that no one should be left behind due to the prohibitive costs of essential medical technology, and we are excited to continue paving the way toward more accessible, cutting-edge healthcare solutions worldwide.